CLINICAL_TRIALS ClinicalTrials.gov record update

Study to Assess Immunogenicity, Reactogenicity and Safety of 1 Dose of GSK Biologicals' Meningococcal Vaccine GSK134612 vs. 1 Dose of Sanofi-Pasteur's Menactra® in Healthy Subjects 10-25 Years.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00454909
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:54.129192+00:00
Published At: 2017-04-12T00:00:00+00:00
Record Updated At: 2018-06-08
Results Posted At: 2017-04-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Infections, Meningococcal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-06-08"
protocolSection.identificationModule.nctId: "NCT00454909"
protocolSection.identificationModule.officialTitle: "Study to Assess Immunogenicity, Reactogenicity and Safety of 1 Dose of GSK Biologicals\u0027 Meningococcal Vaccine GSK134612 vs. 1 Dose of Sanofi-Pasteur\u0027s Menactra\u00ae in Healthy Subjects 10-25 Years."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-04-12"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.